Works matching IS 01435221 AND DT 2018 AND VI 132 AND IP 10
Results: 5
PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate.
- Published in:
- Clinical Science, 2018, v. 132, n. 10, p. 1075, doi. 10.1042/CS20180040
- By:
- Publication type:
- Article
Leflunomide counter akts cardiac hypertrophy.
- Published in:
- Clinical Science, 2018, v. 132, n. 10, p. 1069, doi. 10.1042/CS20180228
- By:
- Publication type:
- Article
Neuroprotection via AT<sub>2</sub> receptor agonists in ischemic stroke.
- Published in:
- Clinical Science, 2018, v. 132, n. 10, p. 1055, doi. 10.1042/CS20171549
- By:
- Publication type:
- Article
Recent advances in the detection of brown adipose tissue in adult humans: a review.
- Published in:
- Clinical Science, 2018, v. 132, n. 10, p. 1039, doi. 10.1042/CS20170276
- By:
- Publication type:
- Article
The depressor axis of the renin-angiotensin system and brain disorders: a translational approach.
- Published in:
- Clinical Science, 2018, v. 132, n. 10, p. 1021, doi. 10.1042/CS20180189
- By:
- Publication type:
- Article